BioNTech SE (BNTX) Net Equity Issued and Repurchased (2018 - 2022)

BioNTech SE (BNTX) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $124.0 million in Q1 2022.

• For the quarter ending Q1 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $124.0 million; the trailing twelve-month figure through Dec 2022 stood at $124.0 million (down 37.82% YoY), and the FY2022 full-year result was $112.7 million, down 40.79% from the prior year.
• Net Equity Issued and Repurchased grew to $124.0 million in Q1 2022, from -$184.1 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $193.8 million in Q2 2021 to a low of -$321.1 million in Q4 2018.
• A 5-year average of -$38.9 million and a median of $86.92 in 2020 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased jumped 100.0% in 2020 and slumped 211768748.9% in 2021, its largest moves.
• Tracing BNTX's Net Equity Issued and Repurchased over 5 years: stood at -$321.1 million in 2018, then increased by 14.57% to -$274.4 million in 2019, then jumped by 100.0% to $86.92 in 2020, then tumbled by 211768748.9% to -$184.1 million in 2021, then jumped by 167.38% to $124.0 million in 2022.
• Business Quant data shows BNTX's Net Equity Issued and Repurchased at $124.0 million in Q1 2022, -$184.1 million in Q4 2021, and $189.7 million in Q3 2021.